Health
Wellness expert reveals surprising health benefits of daily cold exposure: ‘Huge difference’
NEWYou can now listen to Fox News articles!
Interview of the week
Wim Hof breaks down his three-pillar method for more energy, less stress
Top stories
→ First case of severe mpox disease reported in major city
→ Deadly meningitis outbreak prompts college students to call for campus shutdown
→ Mom with no symptoms had colorectal cancer — and a rare surgery saved her life
A Los Angeles mother said her jarring symptoms were dismissed by doctors for years, chalked up to a side effect of childbirth, but they turned out to be signals of colorectal cancer. (Amy Piccioli)
Rises and falls
→ Cigarette smoking plummets to historic single-digit low in U.S.
→ Male fertility rates decline as experts reveal health threats
→ Surges in adult ADHD stimulant prescriptions have doctors concerned
Conversation starters
→ Canadian patients left waiting 15+ hours in emergency room
→ The real reason for sagging jowls, and what will and won’t help
→ Study reveals surprising results after stopping GLP-1 weight-loss drugs
CLICK HERE FOR MORE HEALTH STORIES
Health
Sleep apnea may be quietly changing your body in an unexpected way, study finds
NEWYou can now listen to Fox News articles!
Researchers in Israel have discovered a difference in muscle structure in those with obstructive sleep apnea (OSA).
According to a new study published in the journal Sleep and Breathing, people with OSA tend to have a higher muscle mass index, reflecting greater area relative to height, as well as lower density.
This means people with OSA may look like they have more muscle, but that muscle tends to be less dense and potentially less functional.
POPULAR SLEEP POSITIONS COULD BE DAMAGING YOUR NERVES, ACCORDING TO EXPERTS
The researchers gathered data from 209 adults in an overnight sleep study who underwent chest or abdominal CT scans, according to a press release.
Compared with a control group, the researchers found that people with OSA were older, more often male and heavier on average. They were also more likely to have hypertension, cardiovascular disease and poorer oxygen levels during sleep.
People with sleep apnea had a higher muscle mass index, yet the quality of that muscle was reduced. (iStock)
The findings showed a significant link between OSA and higher muscle mass index. However, lower muscle density was more strongly associated with age and weight than with OSA.
Worse sleep apnea severity was linked with lower skeletal muscle density (SMD) and higher skeletal muscle index (SMI), indicating larger but less dense muscle.
SIMPLE NIGHTLY HABIT LINKED TO HEALTHIER BLOOD PRESSURE, STUDY SUGGESTS
Higher BMI was strongly linked with lower SMD and higher SMI, while older age was strongly linked with lower SMD.
Individuals over 60 years old and those with a BMI over 30 had much stronger links to lower muscle density than OSA alone, according to the research.
“These findings highlight that OSA is much more than a nighttime breathing disorder.”
Dr. Wendy Troxel, a Utah-based licensed clinical psychologist and senior behavioral scientist at RAND, simplified the main study findings in an interview with Fox News Digital.
“Individuals with OSA may have more muscle mass, but that muscle may be less healthy because it contains more fat, which can impair strength and metabolic function,” said Troxel, who was not involved in the study.
Individuals over 60 years old and those with a BMI over 30 had much stronger links to lower muscle density than OSA alone. (iStock)
“This pattern overlaps with sarcopenia, a clinical condition where muscle becomes weaker and less efficient, even if muscle size doesn’t dramatically decline.”
Troxel pointed out an “important” association between OSA severity and muscle quality, which was “modest compared to known risk factors, including age and body mass.”
SLEEP PATTERNS COULD PREDICT RISK FOR DEMENTIA, CANCER AND STROKE, STUDY SUGGESTS
“[This indicates] that OSA may be one marker within a broader profile of metabolic risk,” she said.
“Clinically, these findings highlight that OSA is much more than a nighttime breathing disorder. It may signal underlying metabolic dysfunction affecting multiple systems, including muscle health.”
“These findings highlight that OSA is much more than a nighttime breathing disorder,” a sleep expert commented. (iStock)
In an interview with Fox News Digital, study co-author Ariel Tarasiuk, professor at the department of physiology and cell biology at Israel’s Ben-Gurion University of the Negev, shared his thoughts on the “paradoxical” findings.
“Age and obesity appeared to have a stronger influence on muscle health than sleep apnea itself,” he said. “This suggests that while sleep apnea may play a role, it is unlikely to be the primary factor driving these changes.”
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Patients should be aware that sleep apnea is not just about snoring or poor sleep, Tarasiuk said, as it can affect overall health, including muscle function.
“Getting properly diagnosed and treated matters,” he said. “CPAP therapy can make a real difference in improving breathing and sleep quality, but it’s only part of the picture.”
CLICK HERE FOR MORE HEALTH STORIES
“Maintaining a healthy weight and staying physically active are equally important for muscle health and for reducing the severity of sleep apnea,” he went on. “In short, treating sleep apnea is about protecting long-term health, not just getting a better night’s sleep.”
Keeping a healthy weight and staying active is important in reducing the severity of sleep apnea, according to the researchers. (iStock)
Tarasiuk reminded clinicians that larger muscles don’t always mean healthier, as some muscles may be infiltrated with fat, which may reduce their strength and performance.
“This highlights the importance of looking beyond muscle size alone,” he said. “Routine imaging, such as CT scans performed for other reasons, can sometimes provide additional insight into muscle quality.”
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
“Overall, the findings point toward a more holistic approach: treating the airway while also focusing on weight, physical activity and metabolic health.”
“CPAP therapy can make a real difference in improving breathing and sleep quality, but it’s only part of the picture.”
The study findings may not apply to all populations, as it was conducted at a single center, according to Tarasiuk.
The researchers also did not have access to information on lifestyle factors like physical activity, diet, smoking or alcohol use, factors that can influence muscle health.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
“Looking ahead, larger studies across multiple centers will help confirm these findings and provide a broader picture,” Tarasiuk added.
“Future research will also focus more on outcomes that matter in real life, such as how patients respond to treatments like CPAP, and on understanding how muscle changes develop over time in people with sleep apnea.”
Health
IV therapy and supplements under scrutiny as experts warn of potential side effects
Medical expert analyzes trending IV therapy, concerns about peptides
Dr. Mike Varshavski joins ‘Fox & Friends’ for Wellness Week, examining trending self-care treatments. He evaluates IV vitamin therapy, highlighting its hospital-critical role versus unproven benefits for general wellness, citing potential risks like vitamin imbalance. Dr. Mike also differentiates creatine, a research-backed supplement, from unregulated peptides marketed with unverified anti-aging and muscle growth promises, urging caution for patients.
NEWYou can now listen to Fox News articles!
As “Fox & Friends” continues its Wellness Week, the conversation has turned toward IV drips, peptides and creatine, with a focus on whether they are helpful health hacks or overblown hype.
The segment featured Lawrence Jones undergoing IV therapy. According to the clinic staff, the treatment is designed to help with stress and overall wellness, making patients “less likely to get sick.”
Jones was treated with a cocktail of B vitamins, high-dose vitamin C, magnesium and amino acids.
DO RED LIGHT THERAPY AND COLD PLUNGES REALLY WORK? A DOCTOR REVEALS THE TRUTH
The staff also touted the benefits of NAD, claiming it “is going to clear up any brain fog” and is “amazing for physical injury.”
When asked about potential downsides, the clinician told Jones, “Honestly, there are no negative side effects,” and suggested that “you should sleep really well, wake up really well-rested to your first alarm.”
Peptides have gained popularity for outcomes like building muscle, healing injuries or appearing younger. (iStock)
However, family medicine physician Dr. Mike Varshavski expressed concern over the lack of informed consent and the nature of the claims.
SUPPLEMENT HEALTH RISKS TO KNOW ABOUT, PLUS A CELEBRITY’S ‘BRUTAL’ INFECTION
“It’s tough to say what actually happened in that visit because there were a lot of promises being made,” said the New Jersey-based doctor.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
He compared the human body to a car’s fuel tank, warning that “putting more and having it spill all over the place just creates added side effects.”
The doctor warned that fat-soluble vitamins “can actually build up in your fat stores and create toxicities.” (iStock)
Varshavski noted that over-supplementing is not a harmless endeavor.
CLICK HERE FOR MORE HEALTH STORIES
Fat-soluble vitamins “can actually build up in your fat stores and create toxicities,” he said, adding that high levels of vitamin B have been associated with a higher cancer risk.
The conversation then shifted to creatine and peptides.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Varshavski was supportive of creatine, stating that it “actually has great evidence behind it” for explosive movements, though he clarified that it accounts for only about 5% of total fitness enhancements.
The doctor described the use of unregulated injectable peptides as “incredibly frightening.” (iStock)
In contrast, he described the use of unregulated injectable peptides as “incredibly frightening.”
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
The FDA does not regulate many of these products, leaving patients vulnerable to “black-market” substances sold for “research use only,” Varshavski cautioned.
When it comes to vitamins and miracle cures, he concluded, “it’s not as simple as more equals better.”
Health
Supreme Court Asked to Restore Access to Abortion Pill by Mail
Two manufacturers of the abortion pill mifepristone asked the Supreme Court on Saturday to immediately restore full access to the medication, putting the contentious issue of abortion back before the justices in a midterm election year.
The requests came after a lower court on Friday temporarily restricted abortion providers nationwide from prescribing the pills by telemedicine and sending them to patients by mail. That process is one of the main ways women seeking abortions have obtained the medication in recent years.
If the order on Friday by a federal appeals court is upheld, it could sow confusion and upend a major avenue for abortion access across the country — not just in states with abortion bans. About one-fourth of abortions in the United States are now provided through telemedicine.
Louisiana officials had sued the Food and Drug Administration to restrict access to mifepristone, saying the availability of the medication by mail had allowed abortions to continue in the state despite its near-total ban on abortion.
A three-judge panel of the U.S. Court of Appeals for the Fifth Circuit on Friday sided with Louisiana and essentially reimposed an F.D.A. requirement that health care providers prescribe mifepristone only after seeing patients in person. That rule was first lifted in 2021. The Fifth Circuit ordered that in-person dispensing of mifepristone be reinstated until the Louisiana lawsuit made its way through the courts.
The manufacturers, Danco Laboratories and GenBioPro, are also defendants in the Louisiana lawsuit. On Saturday afternoon, Danco filed an emergency request asking the Supreme Court to lift the lower court’s order, which applied to patients across the country. GenBioPro filed a similar request Saturday evening.
“The Supreme Court must reject this unfounded and baseless attack on an essential medication,” GenBioPro’s chief executive, Evan Masingill, said on Saturday, adding: “We remain concerned that anti-abortion special interests are attempting to undermine the U.S. Food and Drug Administration’s regulatory authority. This is why we are bringing our fight to the Supreme Court.”
In its filing, GenBioPro said that “patients and clinicians have, for years, relied on dispensing mifepristone without an in-clinic visit, particularly for women from rural areas and those for whom transportation, child care or occupational constraints make it difficult to see providers in person.”
It said that the Fifth Circuit’s order “is deeply unsettling to drug sponsors, health care providers, patients and the public — all of whom rely on F.D.A.’s exercise of scientific judgment and orderly administration of the Nation’s complex system of drug regulation.”
In its filing, Danco said the Fifth Circuit’s ruling “injects immediate confusion and upheaval into highly time-sensitive medical decisions,” and requires Danco, providers, patients and pharmacies “all to guess at what is allowed and what is not.”
In a motion filed on Friday night asking the Fifth Circuit to pause its order, Danco said that the ruling would cause “chaos.” The court had not responded to the request by Saturday evening.
The Trump administration has defended the F.D.A. in court, but has not said in this case, or in public statements, whether it supports keeping in place the regulations that allow for pills to be mailed. Rather, it has said that the F.D.A. is conducting a review of mifepristone. It has also asked the court to delay the lawsuit proceedings until that review is complete.
Administration officials recently told The New York Times that the review would not be finished until the end of this year, a time frame that would fall after the midterm elections.
The mifepristone case puts the Trump administration in a politically tricky position, given that many of President Trump’s supporters oppose abortion. The Justice Department has not responded to requests for comment about whether it would appeal to the Supreme Court.
On Saturday, a spokesman for the Department of Health and Human Services, which oversees the F.D.A., declined to comment, citing “ongoing litigation.”
Following the Supreme Court’s decision in 2022 to eliminate the nationwide right to abortion, Republican-led states like Louisiana imposed strict bans on abortion. In response, many Democratic-led states passed shield laws that protect abortion providers who prescribe pills by telemedicine and send them to patients in states with abortion bans.
Nearly two-thirds of abortions in the United States are now carried out with abortion pills, typically used through the first 12 weeks of pregnancy. The medication abortion regimen usually involves taking mifepristone, which blocks a hormone necessary for pregnancy to continue, followed 24 to 48 hours later by a second medication, misoprostol, which causes contractions similar to a miscarriage. The Louisiana case targets mifepristone, which the F.D.A. approved for abortion in 2000. Misoprostol, which is also used for other medical conditions, is not affected by the Fifth Circuit ruling.
During the coronavirus pandemic, the F.D.A. lifted its requirement that patients visit a medical provider in person to obtain mifepristone. That decision was made permanent in 2023 and led to the creation of numerous telemedicine abortion services.
Louisiana has claimed in its lawsuit that the F.D.A.’s decision to remove the in-person dispensing requirement was based on inadequate or flawed data — an assertion medical organizations dispute, pointing to more than 100 studies that have found that mifepristone is safe, and that serious complications from taking it are rare.
In addition, Louisiana said that the regulations had resulted in numerous illegal abortions in the state, and that it had paid thousands of dollars in Medicaid bills for women harmed by mifepristone.
In its Supreme Court filing, GenBioPro said Louisiana’s “narrative is demonstrably false,” adding that the F.D.A.’s regulation change allowing telemedicine prescribing and pills by mail “does not require anyone to prescribe mifepristone, require anyone to dispense mifepristone or prevent Louisiana from creating or enforcing its abortion prohibitions. It simply removes a federal in-person dispensing requirement.”
In April, a district court judge in Louisiana said the state was likely to win its challenge to the regulation, but declined to pause the availability of pills by mail. Instead, the judge gave the F.D.A. time to complete the safety review of mifepristone.
In its ruling Friday, the Fifth Circuit sided with Louisiana, echoing the state’s arguments that the F.D.A.’s regulations were “undermining its laws protecting unborn human life” and also “causing it to spend Medicaid funds on emergency care for women harmed by mifepristone,” according to the order written by Judge Stuart Kyle Duncan, a Trump appointee. He was joined by Judge Kurt D. Engelhardt, another Trump appointee, and Judge Leslie Southwick, an appointee of President George W. Bush.
Other litigation over access to abortion medication has been making its way through the federal courts.
In 2024, the Supreme Court declined to limit access to mifepristone in a case brought by anti-abortion doctors and groups that sought to have its approval revoked. The court unanimously sided with the Biden administration and the manufacturer of mifepristone, and said the plaintiffs did not have legal grounds to bring the challenge.
The case was revived later that year, and is pending before a federal court in Missouri. Another similar case was filed against the F.D.A. last year by Texas and Florida.
-
Health51 seconds agoSleep apnea may be quietly changing your body in an unexpected way, study finds
-
Sports7 minutes agoWWE star Chelsea Green reveals she underwent ‘heart procedure’ to address SVT
-
Technology13 minutes agoInstantly upgrade your streaming: At home and when traveling
-
Business19 minutes agoCrypto exchange Coinbase to lay off 14% of staff as AI reshapes work
-
Entertainment25 minutes agoWhitney Leavitt is leaving ‘Secret Lives of Mormon Wives’ after Season 5 wraps
-
Lifestyle31 minutes agoHow to have the best Sunday in L.A, according to Halle Bailey
-
Politics37 minutes agoElections officials urge early mail-in voting, warn about ‘misinformation’
-
Science43 minutes agoDeadly hantavirus outbreak strikes luxury cruise. What you should know about the disease